◼ Archived
Health
Women On GLP-1s Are Revealing The Side Effects And Experiences No One Told Them About
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Glp-1S
48 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
Women On GLP-1s Are Revealing The Side Effects And Experiences No One Told Them About
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
What to know about GLP-1s and cannabis use
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Can GLP-1s heal the brain? Obesity drugs get a makeover for addiction and depression
Obesity drugs face a major pivot as clinical trials investigate their potential to treat addiction, depression, and criminal behavior.
◼ Archived
Health
GLP-1s may help boost fertility outcomes for hopeful mothers, some women find
Recent reporting examines whether GLP-1 weight-loss medications could help women conceive and boost fertility outcomes.
◼ Archived
Health
Weight loss with GLP-1s: What are the best ways to maintain results?
Recent coverage examines what happens when individuals stop taking GLP-1 weight loss and diabetes medications.
◼ Archived
Health
Ongoing lawsuits allege GLP-1s can cause serious harm. But we don't know how often
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Scientists find two things that may limit weight regain after stopping GLP-1s
Recent scientific findings point to potential methods for limiting weight regain after patients stop taking GLP-1 medications.
◼ Archived
Health
What parents should know about GLP-1s for kids
Recent coverage examines the rising use of GLP-1 medications among children, highlighting strong weight loss alongside nutritional and data gaps.
◼ Archived
Business
How GLP-1s are reshaping cultural views on body image
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
How GLP-1s are reshaping cultural views on body image
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
GLP-1s linked to a nasty side effect in nails: study
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
The evidence suggesting GLP-1s can curb drug and alcohol cravings
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
High cost of GLP-1s drives some to seek cheaper, unregulated versions
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Some who take GLP-1s are suffering serious side effects, but it's unclear how often
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
New study suggests possible connection between GLP-1s and hair loss in men
Recent studies link popular GLP-1 weight-loss drugs to surprising physical side effects including hair loss and nail troubles.
◼ Archived
Business
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Once described as obesity medicines for 'patients,' GLP-1s are increasingly lifestyle drugs for 'customers'
GLP-1 medications are shifting from clinical obesity treatments for patients to lifestyle products for customers, amid a surge in oral pill options.
◼ Archived
Business
McDonald's reveals major changes coming to menus, including a shift due to GLP-1s
McDonald's announces massive investments in menu updates, artificial intelligence, and PlayPlaces amid rising customer cost concerns.
◼ Archived
Health
Is long-term use of GLP-1s safe?
Medical and lifestyle experts are questioning the long-term safety and efficacy of GLP-1 medications as they transition from clinical tools to consumer drugs.
◼ Archived
Business
Hundreds of lawsuits allege GLP-1s like Ozempic, Wegovy, Mounjaro caused vision loss
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Nearly 1 in 6 Kids on GLP-1s Developed This Problem Within a Year
New research indicates nearly 17% of children using GLP-1 receptor agonists developed nutritional deficiencies within one year of treatment.
◼ Archived
Health
The dangerous risks of stopping Ozempic and GLP-1s
New reports warn that discontinuing GLP-1 weight-loss medications like Ozempic, Mounjaro, and Wegovy may increase the risk of heart attack and stroke.
◼ Archived
Business
Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Millions of parents are taking GLP-1s. How should they talk to their kids about it?
As GLP-1 use rises among millions of parents and an increasing number of children, new medical data warns of nutritional risks for youth.
◼ Archived
Business
Use of GLP-1s Like Ozempic Is Forcing Food Companies to Adapt
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
(Un)intended consequences of mass-prescribing GLP-1s
Recent reporting examines the widespread prescribing of GLP-1 medications and their broad societal and biological impacts.
◼ Archived
Health
🔮 fades ✓
Don’t take GLP-1s? Be prepared to explain yourself.
A growing cultural and medical debate is emerging over the use of GLP-1 medications, focusing on the tension between clinical benefits and social stigma.
◼ Archived
Health
🔮 fades ✗
'Microdosing' GLP-1s can shed pounds, but here are the dangers
Concerns grow over the 'microdosing' of GLP-1 weight-loss medications as reports emerge regarding their effectiveness at low doses and long-term maintenance.
◼ Archived
Health
🔮 fades ✗
GLP-1s may work by activating an unlikely weight loss ally
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
GLP-1s may have a host of other health benefits. Just ask these people
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
Could GLP-1s help with alcohol use disorder? A Philly VA doctor is leading a national trial to find out.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
GLP-1s Left Their Hair 'Falling Out In Fistfuls'
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
A New Use for GLP-1s? Amylyx Pharma Catapults To 3-Year High
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
Kids are always watching. What parents on GLP-1s should consider about their body changes
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
GLP-1s May Be Working in an Entirely Different Way Than We Thought
New scientific discoveries regarding brain circuits may redefine the understood mechanism of GLP-1 weight loss drugs like Ozempic and Wegovy.
◼ Archived
Health
🔮 fades ✗
Unexpected brain mechanism challenges assumptions about GLP-1s
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
7 Surprising Benefits Of GLP-1s That Are Not About Weight Loss
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
5 Hidden Side Effects Of GLP-1s To Consider Before Treatment
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
I Spent 8 Weeks On A GLP-1s, And Honestly? It Wasn't At All What Social Makes It Seem Like
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
A Doctor’s View On GLP-1s: A Brave New World Weight Loss Plan
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
Why your health plan doesn’t cover GLP-1s, according to a top insurance exec
Insurance executives and employers are redefining access to GLP-1 weight-loss medications amid shifting coverage trends and affordability challenges.
◼ Archived
Business
🔮 fades
Number of Americans taking GLP-1s for weight loss hits record high: Survey
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
People Are Sharing The Things They Think Will Be “Inevitable Outcomes” Of GLP-1s Over The Next 20 Years
Social media discourse and emerging clinical research are converging on the long-term potential of GLP-1 agonists beyond weight management.
◼ Archived
Health
🔮 fades
Can GLP-1s Treat Cancer? What the Latest Science Says About Ozempic’s Newest Benefit
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
GLP-1s drugs like Ozempic may actually boost fertility in men: study
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Sports
🔮 fades
Serena Williams’ comeback at the Queen’s Club is over after injury to doubles partner
Serena Williams' Queen’s comeback ends abruptly as injury to her doubles partner reshapes her return narrative